Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Comparison of the effects of spironolactone and moxonidine as the fourth component of the resistant hypertension therapy on the arterial stiffness, Ukrainian Therapeutical Journal, June 2022, Publishing Company VIT-A-POL,
DOI: 10.30978/utj2022-1-16.
You can read the full text:
Contributors
The following have contributed to this page